Abstract:Adriana Maldonado-Franco, 1 Luis F Giraldo-Cadavid, 2, 3 Eduardo Tuta-Quintero, 2 Mauricio Cagy, 4 Alirio R Bastidas Goyes, 2 Daniel A Botero-Rosas 2 1 School of Engineering, Universidad de La Sabana, Chía, Colombia; 2 School of Medicine, Universidad de La Sabana, Chía, Colombia; 3 Interventional Pulmonology Service, Fundación Neumológica Colombiana, Bogotá, DC, Colombia; 4 Biomedical Engineering Program, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil Correspondence: Daniel A Botero-Rosas, Universidad de La Sabana, Morphophysiology Department, Km 7, Northern Highway, Chía, Cundinamarca, 140013, Colombia, Email Background: Development of new tools in artificial intelligence has an outstanding performance in the recognition of multidimensional patterns, which is why they have proven to be useful in the diagnosis of Chronic Obstructive Pulmonary Disease (COPD). Methods: This was an observational analytical single-centre study in patients with spirometry performed in outpatient medical care. The segment that goes from the peak expiratory flow to the forced vital capacity was modelled with quadratic polynomials, the coefficients obtained were used to train and test neural networks in the task of classifying patients with COPD. Results: A total of 695 patient records were included in the analysis. The COPD group was significantly older than the No COPD group. The pre-bronchodilator (Pre BD) and post-bronchodilator (Post BD) spirometric curves were modelled with a quadratic polynomial, and the coefficients obtained were used to feed three neural networks (Pre BD, Post BD and all coefficients). The best neural network was the one that used the post-bronchodilator coefficients, which has an input layer of 3 neurons and three hidden layers with sigmoid activation function and two neurons in the output layer with softmax activation function. This system had an accuracy of 92.9% accuracy, a sensitivity of 88.2% and a specificity of 94.3% when assessed using expert judgment as the reference test. It also showed better performance than the current gold standard, especially in specificity and negative predictive value. Conclusion: Artificial Neural Networks fed with coefficients obtained from quadratic and cubic polynomials have interesting potential of emulating the clinical diagnostic process and can become an important aid in primary care to help diagnose COPD in an early stage. Keywords: artificial neural networks, machine learning, diagnosis, accuracy, COPD Chronic Obstructive Pulmonary Disease (COPD) is a respiratory condition that causes persistent airflow obstruction, due to alterations in the airways and/or in the alveoli, which result in chronic respiratory symptoms such as cough and dyspnoea. 1 Even though COPD is a preventable and treatable disease, it is the third leading cause of death worldwide, with a higher burden on low- and medium-income countries. 2 For example, in Latin America, the PLATINO Study found a 14.3% COPD prevalence, ranging from 7.8% in Mexico City to 19.7% in Montevideo, Uruguay. 3 Globally, more than 3 million deaths were attributed to COPD in 2019 alone, 4 and the disease prevalence is only expected to increase in the following years, because of the world's population aging and continuous exposure to noxious particles or gases, like tobacco smoking and air pollution. 5 Due to its progressive nature, timely diagnosis of COPD is key to manage disease development by taking protective measures and treating symptoms, improving the prognosis for the patient. 6 Current international guidelines indicate that any subject exposed to at least one risk factor should be tested for COPD with spirometry, and the ratio between the Forced Expiratory Volume in the first second (FEV 1 ) and the Forced Vital Capacity (FVC), after applying a bronchodilator, is evaluated. If this ratio results to be under 0.7 (70%), the patient is diagnosed with COPD. 1 However, authorities like the American Thoracic Society (ATS) and the European Respiratory Society (ERS) advise considering the statistically derived lower limit of normal (LLN) as well. 7 Even though there has been a global effort in improving its diagnosis, COPD still has high underdiagnosis and misdiagnosis rates. For instance, the PUMA Study, which was conducted in Argentina, Colombia, Uruguay, and Venezuela in 2016, found an underdiagnosis prevalence of 77% and a misdiagnosis rate of 30.4%. 8 The FEV 1 /FVC ratio only considers two instantaneous measures of the spirometry, but more information can be gathered from the flow-volume curve sha -Abstract Truncated-

Race Adjustment of Pulmonary Function Tests in the Diagnosis and Management of COPD: A Scoping Review

Race-Based Pulmonary Function Testing Correction in COPD Inhaler Therapy Trials: A Systematic Review

Implications of Race Adjustment in Lung-Function Equations

The Impact of Changing Race-Specific Equations for Lung Function Tests among Veterans with Chronic Obstructive Pulmonary Disease

Use of the Spirometric "Fixed-Ratio" Underdiagnoses COPD in African-Americans in a Longitudinal Cohort Study

Race-Specific Spirometry Equations Do Not Improve Models of Dyspnea and Quantitative Chest CT Phenotypes

The Challenge of Implementing Race-Neutral PFT Reference Equations

Race-Neutral Equations and Pulmonary Function Test Interpretation in Two Pediatric Cohorts

The impact of switching to race-neutral reference equations on FEV 1 percent predicted among people with cystic fibrosis ,

Implications of Global Lung Function Initiative Spirometry Reference Equations in Northeast Asian Patients With COPD

Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification

Association of Preoperative Lung Function with Complications after Lobectomy Using Race-Neutral and Race-Specific Normative Equations

Abstract A106: Are we there yet? Performance of risk-model based eligibility for lung cancer screening

The effect of health disparities on racial gaps in lung function

Ethnicity corrections in pulmonary function test reports: what to do?

The Implication of Dropping Race from the MDRD Equation to Estimate GFR in an African American-Only Cohort

Spirometry Interpretation After Implementation of Race-Neutral Reference Equations in Children

Curve-Modelling and Machine Learning for a Better COPD Diagnosis

Disease Burden and Health-Related Quality of Life (HRQoL) of Chronic Obstructive Pulmonary Disease (COPD) in the US – Evidence from the Medical Expenditure Panel Survey (MEPS) from 2016-2019

Race adjustments in clinical algorithms can help correct for racial disparities in data quality

Algorithmic Changes Are Not Enough: Evaluating the Removal of Race Adjustment from the eGFR Equation